Long Nguyen, Medical Oncologist at Vietnam National Cancer Hospital, shared on LinkedIn:
“Excited to share that I will be serving on the Executive Board of the Vietnam Young Physicians’ Association for Oncology (VYPAO) for the 2026-2031 term.
I look forward to working with colleagues to create more training, mentorship, and career development opportunities for young oncologists in Vietnam, while building stronger connections with international oncology organizations.
About VYPAO
The VYPAO is a specialized national sub-association under the Vietnam Young Physicians Association.
In November 2026, the association convened its 2nd National Congress (Term 2026-2031) in Hanoi. The convention marked a significant milestone for the organization, assembling leading young medical oncologists, surgical oncologists, radiation therapists, and researchers from across the country to advance clinical practice, scientific inquiry, and multidisciplinary cancer care.
The Congress democratically elected 41 members to its Executive Board for the 2026-2031 tenure.
Dr. Ho Xuan Dung, Vice Head of the Department of Oncology at Hue University of Medicine and Pharmacy and Deputy Head of the Oncology Center at Hue University Hospital, was appointed as the new President of the association. Under this newly established leadership, the organization aims to strengthen academic exchanges, support young residency programs, and expand evidence-based oncological standards across clinical networks in Vietnam.
Immediately following the executive proceedings, the association hosted a specialized national scientific symposium focused on ‘Endometrial Cancer: Current Management Strategies and Future Trends‘. The conference featured seven comprehensive clinical presentations detailing:
- molecular pathology classification,
- genetic screening,
- precision radiation therapy,
- targeted therapies,
- immunotherapies,
- and antibody-drug conjugates (ADCs).
A core objective of the scientific program was aligning multidisciplinary endometrial cancer protocols in domestic practice with the latest global consensus guidelines from NCCN, ESMO, and ASCO, adapting high-tier therapeutic strategies to local clinical environments.”
Other articles about Long Nguyen on OncoDaily.